SILu(TM)MAb Bevacizumab Stable-Isotope Labeled Monoclonal Antibody

Descrição detalhada : SILu(TM)MAb Bevacizumab (MSQC21) is a recombinant, stable isotope-labeled, monoclonal antibody which incorporates [13C6, 15N4]-Arginine and [13C6, 15N2]-Lysine. Expressed in CHO cells, it is designed to be used as an internal standard for the quantitative mass spectrometry analysis of Bevacizumab in human serum. SILu(TM)MAb Bevacizumab is for R&D use only. Not for drug, household, or other uses.
Armazenamento : -20C
Embalagem : 1X100UG